Nancy E. Dempze’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.45M | Buy |
28,882
+308
| +1% | +$40.4K | 1.9% | 22 |
|
|
2025
Q4 | $3.89M | Buy |
28,574
+256
| +0.9% | +$36.8K | 2.03% | 19 |
|
|
2025
Q3 | $4.18M | Sell |
28,318
-14
| -0% | -$1.94K | 2.29% | 15 |
|
|
2025
Q2 | $3.67M | Buy |
28,332
+296
| +1% | +$35.8K | 2.11% | 20 |
|
|
2025
Q1 | $3.35M | Buy |
28,036
+2,275
| +9% | +$282K | 2.01% | 22 |
|
|
2024
Q4 | $2.99M | Buy |
25,761
+88
| +0.3% | +$11.1K | 1.73% | 22 |
|
|
2024
Q3 | $3.47M | Buy |
25,673
+2,245
| +10% | +$300K | 1.93% | 22 |
|
|
2024
Q2 | $3.18M | Buy |
23,428
+225
| +1% | +$30.6K | 2.18% | 21 |
|
|
2024
Q1 | $3M | Buy |
23,203
+855
| +4% | +$103K | 2.28% | 23 |
|
|
2023
Q4 | $2.56M | Buy |
22,348
+285
| +1% | +$28.4K | 2.14% | 23 |
|
|
2023
Q3 | $2.01M | Sell |
22,063
-220
| -1% | -$22.7K | 1.8% | 26 |
|
|
2023
Q2 | $2.51M | Buy |
22,283
+1
| +0% | +$106 | 2.15% | 24 |
|
|
2023
Q1 | $2.33M | Buy |
22,282
+462
| +2% | +$48.2K | 2.12% | 23 |
|
|
2022
Q4 | $2.41M | Buy |
21,820
+663
| +3% | +$69.5K | 2.35% | 20 |
|
|
2022
Q3 | $1.85M | Buy |
21,157
+877
| +4% | +$79.7K | 1.97% | 23 |
|
|
2022
Q2 | $1.59M | Sell |
20,280
-4,209
| -17% | -$348K | 1.59% | 26 |
|
|
2022
Q1 | $2.09M | Buy |
24,489
+600
| +3% | +$57.5K | 1.52% | 27 |
|
|
2021
Q4 | $2.87M | Buy |
23,889
+115
| +0.5% | +$14.3K | 1.93% | 22 |
|
|
2021
Q3 | $2.94M | Sell |
23,774
-25
| -0.1% | -$3.22K | 2.31% | 17 |
|
|
2021
Q2 | $2.85M | Sell |
23,799
-231
| -1% | -$26.4K | 2.41% | 19 |
|
|
2021
Q1 | $2.53M | Buy |
24,030
+1,491
| +7% | +$151K | 2.23% | 22 |
|
|
2020
Q4 | $2.29M | Buy |
22,539
+325
| +1% | +$30.5K | 2.11% | 23 |
|
|
2020
Q3 | $1.87M | Buy |
22,214
+1,915
| +9% | +$149K | 1.9% | 24 |
|
|
2020
Q2 | $1.32M | Buy |
20,299
+792
| +4% | +$52.3K | 1.47% | 28 |
|
|
2020
Q1 | $1.27M | Buy |
19,507
+880
| +5% | +$69.3K | 1.71% | 27 |
|
|
2019
Q4 | $1.47M | Buy |
18,627
+15
| +0.1% | +$1.17K | 1.63% | 26 |
|
|
2019
Q3 | $1.48M | Buy |
18,612
+839
| +5% | +$65.9K | 1.8% | 22 |
|
|
2019
Q2 | $1.49M | Buy |
17,773
+420
| +2% | +$33.5K | 1.7% | 24 |
|
|
2019
Q1 | $1.37M | Buy |
17,353
+162
| +0.9% | +$11.8K | 1.62% | 25 |
|
|
2018
Q4 | $1.15M | Sell |
17,191
-470
| -3% | -$32.5K | 1.59% | 26 |
|
|
2018
Q3 | $1.41M | Hold |
17,661
| – | – | 1.58% | 26 |
|
|
2018
Q2 | $1.19M | Sell |
17,661
-1,174
| -6% | -$85.2K | 1.45% | 26 |
|
|
2018
Q1 | $1.45M | Sell |
18,835
-950
| -5% | -$70.2K | 1.79% | 23 |
|
|
2017
Q4 | $1.35M | Buy |
19,785
+1,670
| +9% | +$111K | 1.63% | 25 |
|
|
2017
Q3 | $1.14M | Buy |
18,115
+504
| +3% | +$30.1K | 1.6% | 25 |
|
|
2017
Q2 | $976K | Buy |
17,611
+1,015
| +6% | +$52.9K | 1.4% | 26 |
|
|
2017
Q1 | $834K | Sell |
16,596
-250
| -1% | -$12.2K | 1.28% | 30 |
|
|
2016
Q4 | $835K | Hold |
16,846
| – | – | 1.46% | 25 |
|
|
2016
Q3 | $883K | Buy |
16,846
+86
| +0.5% | +$4.22K | 1.55% | 24 |
|
|
2016
Q2 | $748K | Buy |
16,760
+50
| +0.3% | +$2.17K | 1.33% | 27 |
|
|
2016
Q1 | $682K | Buy |
16,710
+4,675
| +39% | +$172K | 1.2% | 29 |
|
|
2015
Q4 | $439K | Buy |
+12,035
| New | +$435K | 0.84% | 42 |
|
Other funds holding XYL
VCM
VPM
Nancy E. Dempze's XYL Position: Q1 2026 in Review
Nancy E. Dempze increased its Xylem (XYL) stake by 1.1% in Q1 2026, buying an estimated $40.4K and bringing the position to 28,882 shares worth $3.45M. The position accounts for 1.9% of the portfolio, ranked #22.
Nancy E. Dempze first reported a position in XYL in Q4 2015 and has held it in 42 quarters since. The position peaked at $4.18M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.
- Nancy E. Dempze held 28,882 shares of Xylem worth $3.45M as of Q1 2026.
- Nancy E. Dempze bought 308 Xylem shares in Q1 2026, an estimated $40.4K.
- Xylem made up 1.9% of Nancy E. Dempze's portfolio in Q1 2026, its #22 holding.
- Nancy E. Dempze first reported a position in Xylem in Q4 2015 and has held it in 42 quarters since.
- Nancy E. Dempze's Xylem position peaked at $4.18M in Q3 2025.
- 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.
Based on Nancy E. Dempze's 13F filing for Q1 2026, filed 14 May 2026.